Results 11 to 20 of about 38,260 (246)

Cannabinoids as treatment for nausea and vomiting [PDF]

open access: yesFrontiers in Pharmacology, 2016
Despite the advent of classic anti-emetics, chemotherapy-induced nausea is still problematic, with vomiting being somewhat better managed in the clinic. If post-treatment nausea and vomiting are not properly controlled, anticipatory nausea—a conditioned ...
Erin M. Rock, Linda A Parker
doaj   +2 more sources

Olanzapine for Chemotherapy-Induced Nausea and Vomiting [PDF]

open access: yesNew England Journal of Medicine, 2016
Excerpt: Navari and colleagues (July 14 issue)1 report on the use of olanzapine for the prevention of chemotherapy-induced nausea and vomiting.
Rudolph M, Navari, Charles L, Loprinzi
openaire   +7 more sources

Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron [PDF]

open access: yesCancer Management and Research, 2009
Emilio Bajetta, Sara Pusceddu, Valentina Guadalupi, Monika Ducceschi, Luigi CelioMedical Oncology Unit 2, Fondazione IRCCS “Istituto Nazionale dei Tumori”, Milan, ItalyAbstract: Prevention of nausea and vomiting is the main goal of ...
Emilio Bajetta   +3 more
doaj   +1 more source

A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting [PDF]

open access: yesTherapeutics and Clinical Risk Management, 2008
Mark A Ware1, Paul Daeninck2, Vincent Maida31Pain Center, McGill University Health Center, Montréal, Quebec, Canada; 2Pain and Symptom Clinic, CancerCare Manitoba, Winnipeg, Manitoba, Canada; 3University of Toronto, Toronto, Ontario ...
Mark A Ware   +2 more
doaj   +1 more source

Chemotherapy-induced nausea and vomiting: exploring patients’ subjective experience [PDF]

open access: yesJournal of Multidisciplinary Healthcare, 2016
Noor Salihah,1 Nik Mazlan,2 Pei Lin Lua3 1Faculty of Health Sciences, Universiti Sultan Zainal Abidin, Kampus Gong Badak, Terengganu, 2Kulliyyah of Allied Health Sciences, International Islamic University Malaysia, Pahang, 3Community Health Research
Salihah N, Mazlan N, Lua PL
doaj   +1 more source

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics [PDF]

open access: yesCancer Management and Research, 2016
Megan Brafford May,1 Ashley E Glode2 1Department of Pharmacy, Baptist Health Lexington, Lexington, KY, USA; 2Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus ...
May MB, Glode AE
doaj   +1 more source

Chemotherapy-Induced Nausea and Vomiting: The Role of Aprepitant [PDF]

open access: yesMiddle East Journal of Cancer, 2011
Antiemetics are given to cancer patients prior to their chemotherapy sessions to protect them from nausea and vomiting induced by chemotherapy. The responsible health care team member will choose the type of antiemetic required to prevent the patient ...
Muath Mohammed Abu Hilal
doaj   +1 more source

Ice massage on chemotherapy induced nausea and vomiting [PDF]

open access: yesمجله دانشگاه علوم پزشکی بیرجند, 2012
Background and Aim: Nausea and vomiting are the most common side effects of chemotherapy. The aim of the current study was to assess the effect of ice massage applied to the pericardium 6 (P6 or Neigaun) acupuncture point on nausea– vomiting due to
Mehdi Sadeghi Shermeh   +3 more
doaj   +1 more source

Knowledge, practice and perceived barriers towards chemotherapy induced nausea and vomiting in prophylaxis guideline adherence among nurses in oncology units at selected hospitals, in Addis Ababa, Ethiopia, a cross-sectional study

open access: yesBMC Nursing, 2022
Background Chemotherapy-induced emesis can be prevented by the use of recommended guidelines for antiemetic regimens but a research study indicates that in Ethiopia the use of standard antiemetic drug guidelines is very limited.
Deneke Gebre   +3 more
doaj   +1 more source

Patient‐Reported Outcomes with Selpercatinib Treatment Among Patients with RET‐Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO‐001 Trial

open access: yesThe Oncologist, EarlyView., 2021
Abstract Background Medullary thyroid cancer (MTC) standard of care includes multikinase inhibitors (MKIs), which can exacerbate disease‐related diarrhea, primarily because of non‐RET kinase inhibition. We report diarrhea and other patient‐reported outcomes (PROs) with selpercatinib, a highly selective RET inhibitor, among patients with RET‐mutant MTC ...
Lori J. Wirth   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy